SFM
PFE icon

Sphera Funds Management’s Pfizer PFE Stock Holding History

Sphera Funds Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,108
Closed -$82K – 117
2014
Q1 		$82K Sell
2,108
-685,205
-100% -$20.4M 0.02% 110
2013
Q4 		$20M Buy
+687,313
New +$20M 5.56% 4

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sphera Funds Management's PFE Position: Q2 2026 in Review

Sphera Funds Management increased its Pfizer (PFE) stake by 54% in Q2 2026, buying an estimated $2.62M and bringing the position to 286,000 shares worth $6.89M. The position accounts for 0.9% of the portfolio, ranked #39.

Sphera Funds Management first reported a position in PFE in Q4 2013 and has held it in 36 quarters since. The position peaked at $47.6M in Q3 2021. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sphera Funds Management held 286,000 shares of Pfizer worth $6.89M as of Q2 2026.
  • Sphera Funds Management bought 100,000 Pfizer shares in Q2 2026, an estimated $2.62M.
  • Pfizer made up 0.9% of Sphera Funds Management's portfolio in Q2 2026, its #39 holding.
  • Sphera Funds Management first reported a position in Pfizer in Q4 2013 and has held it in 36 quarters since.
  • Sphera Funds Management's Pfizer position peaked at $47.6M in Q3 2021.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.